Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

358 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prophylaxis against disseminated Mycobacterium avium complex with weekly azithromycin, daily rifabutin, or both. California Collaborative Treatment Group.
Havlir DV, Dubé MP, Sattler FR, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Lavelle JP, White AC Jr, Witt MD, Bozzette SA, McCutchan JA. Havlir DV, et al. Among authors: dube mp. N Engl J Med. 1996 Aug 8;335(6):392-8. doi: 10.1056/NEJM199608083350604. N Engl J Med. 1996. PMID: 8676932 Free article. Clinical Trial.
Protease inhibitor-associated hyperglycaemia.
Dubé MP, Johnson DL, Currier JS, Leedom JM. Dubé MP, et al. Lancet. 1997 Sep 6;350(9079):713-4. doi: 10.1016/S0140-6736(05)63513-1. Lancet. 1997. PMID: 9291911 No abstract available.
A randomized evaluation of ethambutol for prevention of relapse and drug resistance during treatment of Mycobacterium avium complex bacteremia with clarithromycin-based combination therapy. California Collaborative Treatment Group.
Dubé MP, Sattler FR, Torriani FJ, See D, Havlir DV, Kemper CA, Dezfuli MG, Bozzette SA, Bartok AE, Leedom JM, Tilles JG, McCutchan JA. Dubé MP, et al. J Infect Dis. 1997 Nov;176(5):1225-32. doi: 10.1086/514116. J Infect Dis. 1997. PMID: 9359722 Clinical Trial.
Prophylaxis with weekly versus daily fluconazole for fungal infections in patients with AIDS.
Havlir DV, Dubé MP, McCutchan JA, Forthal DN, Kemper CA, Dunne MW, Parenti DM, Kumar PN, White AC Jr, Witt MD, Nightingale SD, Sepkowitz KA, MacGregor RR, Cheeseman SH, Torriani FJ, Zelasky MT, Sattler FR, Bozzette SA. Havlir DV, et al. Among authors: dube mp. Clin Infect Dis. 1998 Dec;27(6):1369-75. doi: 10.1086/515018. Clin Infect Dis. 1998. PMID: 9868644 Clinical Trial.
Preliminary guidelines for the evaluation and management of dyslipidemia in adults infected with human immunodeficiency virus and receiving antiretroviral therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group.
Dubé MP, Sprecher D, Henry WK, Aberg JA, Torriani FJ, Hodis HN, Schouten J, Levin J, Myers G, Zackin R, Nevin T, Currier JS; Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group. Dubé MP, et al. Clin Infect Dis. 2000 Nov;31(5):1216-24. doi: 10.1086/317429. Epub 2000 Nov 7. Clin Infect Dis. 2000. PMID: 11073755
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitors.
Kemper CA, Witt MD, Keiser PH, Dubé MP, Forthal DN, Leibowitz M, Smith DS, Rigby A, Hellmann NS, Lie YS, Leedom J, Richman D, McCutchan JA, Haubrich R; California Collaborative Treatment Group #575 Team. Kemper CA, et al. Among authors: dube mp. AIDS. 2001 Mar 30;15(5):609-15. doi: 10.1097/00002030-200103300-00010. AIDS. 2001. PMID: 11316998
358 results